<DOC>
	<DOCNO>NCT00081575</DOCNO>
	<brief_summary>To compare efficacy safety IV tigecycline IV levofloxacin treatment subject CAP require hospitalization .</brief_summary>
	<brief_title>Study Comparing Tigecycline vs. Levofloxacin Subjects Hospitalized With Community-Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Community-Acquired Infections</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Male female subject ≥ 18 year age Bulgaria ≤ 70 year age Subjects hospitalize CAP severity require IV antibiotic treatment least 7 day The presence fever ( within 24 hour randomization ) Any concomitant condition , opinion investigator , would preclude evaluation response make unlikely contemplated course therapy could complete ( eg , life expectancy &lt; 30 day ) . Hospitalization within 14 day onset symptom . Residence longterm care facility nursing home ≥14 day onset symptom .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Bacterial Pneumonia</keyword>
</DOC>